Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Koźmin-Burzyńska A, Matuszczyk M, Krzystanek M. Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2021;37(3):259-266. doi:10.5114/fpn.2021.115645. APA Koźmin-Burzyńska, A., Matuszczyk, M., & Krzystanek, M. (2021). Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 37(3), 259-266. https://doi.org/10.5114/fpn.2021.115645 Chicago Koźmin-Burzyńska, Agnieszka, Maciej Matuszczyk, and Marek Krzystanek. 2021. "Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 37 (3): 259-266. doi:10.5114/fpn.2021.115645. Harvard Koźmin-Burzyńska, A., Matuszczyk, M., and Krzystanek, M. (2021). Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 37(3), pp.259-266. https://doi.org/10.5114/fpn.2021.115645 MLA Koźmin-Burzyńska, Agnieszka et al. "Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 37, no. 3, 2021, pp. 259-266. doi:10.5114/fpn.2021.115645. Vancouver Koźmin-Burzyńska A, Matuszczyk M, Krzystanek M. Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2021;37(3):259-266. doi:10.5114/fpn.2021.115645.